RWC-340B Opposes and Hemophilia Alliance Questions PhRMA and NACHC’s Push to Remake 340B

RWC-340B Hemophilia Alliance wordmarks
RWC-340B rejected and Hemophilia Alliance criticized PhRMA and NACHC's joint plan to restructure the 340B program.

Ryan White Clinics for 340B Access has announced it opposes the drug industry’s joint plan with community health centers to restructure the 340B program, saying it will increase manufacturers’ “already astronomical profits at the expense of safety net providers.”

Hemophilia

Read More »

340B Expected to Be Addressed During U.S. House Hearing Today

E&C committee room
The 340B program is expected to come up today during a U.S. House Energy & Commerce health subcommittee hearing.

Lawmakers and heath care policy experts are expected to discuss the 340B program this afternoon during a U.S. House Energy & Commerce health subcommittee hearing.

The hearing on lowering health care costs through more price transparency and competition starts

Read More »

AHF: Addressing Syphilis Disparities in Franklin County, OH

Aids Healthcare Foundation logo

SPONSORED CONTENT

In 1999, the Centers for Disease Control and Prevention (CDC) launched the National Campaign to Eliminate Syphilis from the United States. The CDC updated its ambitious plan in 2006 and aimed to reduce rates of primary and secondary syphilis to less than 2.2 cases per 100,000 population, congenital syphilis to less than 3.9 cases per 100,000, and the racial disparity between rates of syphilis among Black and White individuals to less than 3:1. Despite having moderate success at the turn of the century, the US is experiencing a drastic resurgence of syphilis. In 2021, the CDC reported 171,074 total cases of syphilis nationally, a 68.4% increase from 2017. Worse, there has been a sharp increase in the number of babies born with syphilis; cases of congenital syphilis rose 184.5% to 2,677 cases between 2017 and 2021.

Like other sexually transmitted infections (STIs), syphilis disparities remain with regards to

Read More »

N.Y. State Health Centers Sue to Stop April 1 Shift of Medicaid Managed Care Drug Benefits to Fee for Service

Evergreen Health wordmark
Buffalo, N.Y.-based health center Evergreen Health and Harlem, N.Y.-based health health center Heritage Health and Housing asked a state court to halt Saturday's scheduled transfer of Medicaid drug benefits from managed care to fee for service.

The clock is ticking down in New York state to the scheduled April 1 transfer of Medicaid managed care drug benefits to Medicaid fee for service—a move that 340B safety net providers say would result in financial disaster.

Evergreen Health,

Read More »

HRSA Posts Two Drug Manufacturer Notices to 340B Entities

Vtama pharmaceutical product tube
Dermavant Sciences is giving refunds to health care providers that paid above the 340B ceiling price for Vtama, a treatment for plaque psoriasis.

Biopharmaceutical company Dermavant Sciences is giving refunds to health care providers that paid above the 340B ceiling price for Vtama, a non-steroidal cream to treat plaque psoriasis.

The U.S. Health Resources and Services Administration posted Dermavant’s notice to 340B covered

Read More »

Confidential Document Fleshes Out ASAP 340B’s Reform Objectives

Excerpt from a confidential PhRMA principles document
PhRMA has written an eight-page document that elaborates on its principles for 340B program reform.

A confidential document composed by Pharmaceutical Research and Manufacturers of America in connection with its 340B program reform initiative with the National Association of Community Health Centers fleshes out a “coalition” vision of the 10-point reform plan that the two

Read More »

340B Hospitals Say Pharma’s Contract Pharmacy Policies Are Costing Them “Billions of Dollars”

340B Hospital savings by drug company bar chart
340B Health says, "For just the first five of the 21 drug companies for which there is a full year of data post-restrictions, the 340B savings for hospitals decreased by an estimated $1.1 billion from 2020 to 2021."

Hospitals’ 340B savings for the first five of the 21 companies to impose conditions on 340B pricing when providers use contract pharmacies decreased by an estimated $1.1 billion from 2020 to 2021, hospital group 340B Health said in a new

Read More »

Four Best Practices for Running Mock Audits

Estefani Ruiz headshot

SPONSORED CONTENT

With new leadership in Congress, the drumbeat for greater scrutiny of 340B will grow. To date, news outlets from The New York Times to The Wall Street Journal have quoted former government officials and pundits who’ve called for more oversight of the 340B program.  It is not just former government officials that are raising concerns, leading lawmakers from both parties are calling on 340B providers to be more transparent and ensure that they are being good stewards of the program.

Regardless of the amount and kind of attention channeled toward the 340B program, it’s always right (and a best practice) for 340B executives and managers to be meticulous. Mock audits are one way for covered entities to closely watch over their 340B program activities. These rehearsals can help program managers, staff, and healthcare employees ensure compliance and pass an audit by the

Read More »

Sean Dickson, Known for 340B Research, Takes Senior Post at Health Insurance Association

Sean Dickson headshot
Sean Dickson, a drug policy expert who has published frequently cited research on 340B, has gone to work for the health insurance industry.

Sean Dickson, a drug policy expert who has published frequently cited research on the 340B program and advised both health care providers and drug manufacturers on 340B compliance, has gone to work for the health insurance industry.

Dickson, most recently

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report